Clinical Trial: [18F]F-AraG PET Imaging in Alzheimer's Disease

U.S., May 29 -- ClinicalTrials.gov registry received information related to the study (NCT07611357) titled '[18F]F-AraG PET Imaging in Alzheimer's Disease' on May 01.

Brief Summary: This study evaluates the use of [18F]F-AraG PET/CT imaging to quantify activated T cell involvement in patients with Alzheimer's disease (AD). Participants will undergo total-body dynamic PET imaging to assess tracer uptake in the brain and peripheral organs. Results will be compared between participants with AD and healthy controls to characterize both central nervous system and systemic immune alterations in AD

Study Start Date: May 16

Study Type: INTERVENTIONAL

Condition: Alzheimer Disease (AD)

Intervention: DRUG: Drug: [18F]F-AraG (PET tracer)

Dose: ...